在肽库中进行小肽筛选的初步研究

以合成六肽ＤＧＧＳＡＡ为模型对在噬菌体肽库中进行小肽筛选做了初步研究。结果表明，含有可形成氢键和离子键残基的小肽能够在噬菌体肽库中进行筛选。并用明显提高了筛选的专一性。     

从组合化学肽库中筛选亲和配基

在亲和色谱研究中 ,建立适合于某种分离对象的亲和色谱体系的关键是寻找适合的亲和配基 .小肽亲和配基具有性质稳定、合成简单、价格低及生物相容性好等特点[1] ,但这类配基也存在着亲和力弱或选择性低的缺点 .因此 ,如何寻找小肽配基以及如何提高小肽配基的亲和力和选择性的问题引起了人们的关注与重视 [1～ 3 ] .组合化学法是一种快速制备大量相关或同类化合物的革新性的方法 [4 ] ,组合肽库包括噬菌体展示肽库和合成肽库 ,这两类肽库均可用于小肽配基的筛选与优化 [1,5] .组合化学法尽管有效 ,但以小肽为目的物进行筛选时 ,往往因肽 -肽…     

利用肽配体库分析蛋清中低丰度蛋白质组

利用肽配体库技术(CPLL)研究了蛋清中的低丰度蛋白质组。考察了盐浓度和洗脱顺序差异对CPLL富集效率的影响。结果表明:盐浓度越高,蛋清蛋白质溶液的离子相互作用越强。利用洗脱溶液解离差异,采用先HOS(有机水溶液)后尿素CHAPS(3-[3-(胆酰胺丙基)二甲氨基]-1-丙磺酸内盐)的洗脱顺序,溶菌酶能够得到高效分离。保持蛋清的原p H 8.8,25 mmol/L KH2PO4,150 mmol/L Na Cl,尿素CHAPS洗脱,是CPLL提供高效富集的前提。通过分析CPLL富集前后的十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDSPAGE)条带差异,采用线性离子阱(LTQ)质谱在蛋清中检出45种低丰度蛋白质,其中两种未见报道。对蛋清中低丰度蛋白质亚细胞的定位分析发现,蛋清蛋白质的分泌蛋白居多。研究结果表明,CPLL技术能够实现蛋清中低丰度蛋白质的高效富集,分析深度达到亚细胞水平。     

组合肽配体库技术富集蛋白研究进展

低丰度蛋白是生物体中重要的活性物质,参与新陈代谢、转录和翻译等多种生理及病理过程,因此对低丰度蛋白的研究具有重要意义。组合肽配体库技术(CPLL)是富集低丰度蛋白的一种有效方法,通过CPLL富集作用可以实现低丰度蛋白的检测与鉴定。该文总结了CPLL应用于不同领域中(包括人体、动物源、植物源等蛋白研究方面)低丰度蛋白样品的富集研究,可为CPLL的进一步应用提供参考。     

利用亲和选择筛选法从组合化学库中筛选新药

组合化学方法可以产生大量的新化合物供新药筛选，但传统的逐一筛选法不能满足如此数量庞大的化合物，因此，针对混合物进行筛选显得非常重要，亲和选择筛选法利用药物作用的靶蛋白与潜在药物之间的亲和活性，使目标化合物与大量无亲和活性的化合物分离，然后只对有亲和活性的化合物进行结构鉴定，从而快速地从大量混合物中找到目标化合物，本文着重讨论了亲和选择筛选的的几种形，相应技术和在组合化学库筛选中的应用，亲和选择筛选大体分为两种方式：一种是将靶蛋白固定在支持物上，有亲和活力的化合物被保留，大量非亲和化合物被洗掉，另一种是在溶液中靶蛋白与混合物库孵育，然后利用受体配基复合物与不结合的游离化合性质的判别进行区分，亲和选择筛选法也适合于化合物的种类和含量都未知的天然提取物的筛选。     

酶联免疫法测定人碱性成纤维细胞生长因子脂质体的包封率

建立了一种灵敏的定量检测人碱性成纤维细胞生长因子(hbFGF)脂质体中hbFGF含量的酶联免疫(ELISA)方法,应用于测定hbFGF脂质体的包封率。通过用hbFGF标准品溶液包被酶标板,加入特异性的鼠抗人hbFGF抗体(一抗)和山羊抗鼠IgG(二抗),采用多因素棋盘滴定方法确定最佳实验条件为:一抗浓度200μg/L,二抗浓度50μg/L。本方法的检出限为0.86μg/L,工作浓度范围1.0~10μg/L,批内RSD为3.95%~4.27%,批间RSD为4.19%~7.21%,不同操作者批内和批间的RSD分别为6.21%和9.12%,可重复性良好。本方法测定hbFGF脂质体超滤液和氯仿提取液中hbFGF含量分别为(3.325±0.193)μg/L和(18.454±1.063)μg/L,组内RSD分别为4.69%和4.52%。hbFGF脂质体包封率为82.06%。本方法特异性高、重复性好、快速、简便,可用于hbFGF脂质体包封率及其它含hbFGF制剂的含量测定。     

磺化壳聚糖的制备及其对生长因子活性的保护作用

以壳聚糖为基材,分别以氯磺酸、三甲胺.三氧化硫和丙磺酸内酯为磺化试剂,制备了3,6-O-磺化壳聚糖(OCS)、2-N-磺化壳聚糖(NCS)和2-N-磺丙基壳聚糖(PCS)3种磺化壳聚糖.采用红外光谱、核磁共振谱证明了磺化壳聚糖的结构,元素分析测定了磺化壳聚糖的磺化率.以组织修复过程中一种重要的活性因子——碱性成纤维细胞生长因子(bFGF)为目标因子,通过体外成纤维细胞培养实验,评价了不同磺化壳聚糖对bFGF活性的保护能力.结果显示,相对于未改性壳聚糖(CS),磺化壳聚糖对成纤维细胞的形态无显著影响.细胞活性检测结果显示,OCS和PCS对bFGF活性无明显的保护能力;NCS能有效提高bFGF促进成纤维细胞活性的能力,其对bFGF活性的保护能力可达肝素70%左右.磺化壳聚糖的bFGF活性保护能力不随磺化率的改变而变化.     

利用噬菌体展示技术筛选放射性标记肺癌靶肽YC11及其生物分布

利用体内噬菌体展示技术筛选了肿瘤特异性结合靶肽, 获得了肺腺癌靶肽CSIHYPLSC(YC11)并对其进行了放射性碘标记. 采用反相高效液相色谱技术(RP-HPLC)分离纯化¹³¹I-YC11和对照肽¹³¹I-NGR, 放化纯度大于99%. 在荷人肺腺癌A549裸鼠体内的分布结果表明, ¹³¹I-YC11的肿瘤/血液放射性计数比为0.62, 肿瘤/心脏放射性计数比为2.06, 肿瘤/肺放射性计数比为1.11, 肿瘤/肝脏放射性计数比为0.81, 略高于¹³¹I-NGR的对应值. ¹³¹I-YC11在肿瘤中的摄取值为2.79%ID/g, 与¹³¹I-NGR在肿瘤中的摄取值(1.61%ID/g)相比, ¹³¹I-YC11的肿瘤摄取高于多肽¹³¹I-NGR.     

大鼠转化生长因子-α的合成

本文报道用固相方法合成大鼠转化生长因子-α。与表皮生长因子受体的竞争试验表明,合成品的活性达98％。     

DNA编码分子库液相筛选方法的新进展

目前, DNA编码分子库技术(DNA-encoded library, DEL)已经成为新药研发中不可或缺的重要技术平台.过去30年DEL技术不断发展成熟, DEL兼容化学反应也发展迅速,极大地改善了DEL的化学多样性,并推动了其在药物发现中的应用.通常, DEL的筛选主要是基于亲和力的固相筛选,将纯化后的靶点蛋白固载在基质上,然后通过物理洗脱的方式将结合分子与背景分子分离开来.近年来,一系列在液相中进行DEL筛选的新方法被研发出来,使得适用于DEL筛选的靶点范围被进一步扩大,揭示了DEL作为有效工具探索基础生物学的潜力.本文综合评述了DEL技术的液相筛选方法及应用,并对DEL技术应用于复杂生物靶点以及功能性筛选进行了展望.     

Screening and Identification of a Targeting Peptide to nGLP-1R from Phage Display Peptide Library

<正>In order to provide the structure information for designing new exendin-4 analogues,a phage display peptide library was screened by targeting the N-terminal extracellular domain of GLP-1R(nGLP-1R).After four rounds of selection,nine sequences were obtained,four of them have higher affinity for nGLP-1R than the others.We chose two of them named X and Y peptides.Isletβ-cell proliferation assay suggested that X and Y peptides didn't have any activity to increase isletβ-cell proliferation.In other words,X and Y peptides were not agonists to GLP-1R.However, the conservative motifs of X and Y peptides provided us useful information to design new exendin-4 analogues.     

Screening Peptide Inhibitors Using Phage Peptide Library with Isocitrate Lyase in Mycobacterium tuberculosis as Target

When devoured by macrophages,Mycobacterium tuberculosis remains persistent in macrophages and gains energy through the glyoxylate bypass to maintain its long-term existence in host cells.Therefore it is possible to stop persistent infections by interdicting the glyoxylate bypass in which the isocitrate lyase(ICL) is the key rate-limiting enzyme and a persistence factor.ICL is the target of anti-TB(TB:tubercular) drugs,which could screen ICL out and effectively inhibit the activity of ICL in Mycobacterium tu...     

Selection of Trypsin Inhibitors in Phage Peptide Library Using Model Pepeide Mimicking the Active Site of Trypsin

Recently,thestudiesofX-rayandmolecularbiologyontheinteractionofproteinssuchasantigen-antibody,hormone-receptorandsoonshowthatonlyasmallportionoftheproteinmo1eculetakespartintheinteractionotherthanthewholemolecule,andshortpeptidesbearingcriticalbindingresiduescanbeusedtochemicallymimicthefoldedantigenicdeterminantsonproteins['1.Wede-signedandsynthesizedamodelpeptidemimickingtheactivesiteoftrypsin(apeptide,DGGSAA)basedonthethree-dimensionalstructureoftrypsinanditscatalyticmechanism[2J,andusedt…     

Affinity Chromatography of Insulin with a Heptapeptide Ligand Selected from Phage Display Library

A heptapeptide phage display library was screened with insulin to find its ligands for affinity chromatography. The peptide was synthesized and coupled to EAH Sepharose 4B (5.4 mol mL^–1 bed). Then, insulin chromatography was carried out with mobile phases of different pH values and by the addition of urea and ethylene glycol. It was found that electrostatic interactions were predominant for the affinity binding, and hydrogen bonding might also contribute somewhat to the affinity. Finally, frontal analysis was performed and the dynamic binding capacity of the affinity column for insulin at 50% breakthrough was estimated at 60.6 mg mL^–1 bed, which was about two times higher than the theoretical binding capacity of the monomeric insulin. The result suggests that insulin was bound in dimer state in a stoichiometric relationship with the coupled peptide, indicating the high binding efficiency of the peptide ligand for insulin.     

Studies on β2-Glycoprotein Ⅰ Recognizing Molecules from a Phage Peptide Library

β2-Glycoprotein I(β2-GPI) has been identified as a cofactor in the recognition of phospholipid Ag cardiolipin (CL) by anticardiolipin Ab(aCL) purified from patients' serum with autoimmune disease. However, there is a considerable controversy as to the anti-β2-GPI -antibodies occurred in aCL. In order to select β2-GPI recognizing molecules, β2-GPI was used as a probe to screen affinity phage clones panned from a phage peptide library. After four cycles of selection, the phage recovery increased from 2.4×10-5% to 1.1×10-3%, indicating that a specific enrichment had been achieved. In order to characterize these phage clones, we investigated their specific binding to β2-GPI and their inhibition of β2-GPI binding to anti-β2-GPI antibodies. Almost 40 percent of clones reflected considerable binding abilities and inhibitory activities towards anti-β2-GPI antibodies. A group of related peptides were identified by DNA sequencing, in which there were seven related peptide sequences, with four of them representing more than once. These peptide sequences display similarities at several positions. Sequence motif (-F-S-L-) was evident in most of the peptides. It suggests that these peptides may specifically block the anti-β2-GPI antibodies binding to β2-GPI. Our result supports the idea that β2-GPI acts as a Ag for these anti-β2-GPI antibodies occurred in the aCL.     

Design of Ligands for Affinity Purification of G-CSF Based on Peptide Ligands Derived from a Peptide Library

Introduction　　 Affinity chromatography is of great interest in pharmaceutical industry as it is simple,fast and is of a high efficiency to purify proteins from a complicated mixture to homogenousones in a single step. The most common affinity ligands are monoclonal antibodies,smallmolecules such as biotin and those specific to the bio-function of the protein of interest,suchas substrates and inhibitors. Although m Ab is less limited by the bioactivity of proteins,itspreparation is a complex …     

雷公藤内酯醇靶蛋白的筛选及其结合的初步验证

采用噬菌体展示肽库技术筛选雷公藤内酯醇的靶蛋白,得到了一个肽段,并通过酶联免疫吸附(ELISA)和免疫共沉淀验证了该片段对雷公藤内酯醇的结合特异性。用Basic Local Alignment Search Tool(BLAST)进行序列对比后,找到了77个匹配序列,其中最为匹配的序列是人类类固醇生成因子-1(hSF-1),因此hSF-1可能是雷公藤内酯醇的一个潜在受体。在大肠杆菌中表达纯化了hSF-1的配体结合域(LBD),荧光光谱实验表明雷公藤内酯醇对hSF-1-LBD有荧光淬灭作用、等温滴定量热(ITC)实验表明雷公藤内酯醇与hSF-1-LBD发生焓驱动的特异性结合,表面等离子体共振(SPR)实验表明雷公藤内酯醇可以与hSF-1-LBD剂量依赖性结合,这些都证实了hSF-1与雷公藤内酯醇存在特异性相互作用。     

Rapid Selection of Phage Se-scFv with GPX Activity via Combination of Phage Display Antibody Library with Chemical Modification

IntroductionReactive oxygen species(ROS) are known to de-stroy biomacromolecules and cause cell injury[1]. Un-der normal circumstances, there is a balance betweenthe production of ROS and their destruction. Many dis-eases, such as brain ischemia, tumor, v…     

Analysis of Peptide Ligand Binding to FGFR1

Simulating annealing algorithm was used in docking computation to predict a selected peptide VYMSPF(P2) binding site on the ectodomain of FGFR1.The peptide is located on the hydrophobic surface of the receptor,which is critical for FGF binding.The synthesized peptide can effectively inhibit the mitogenic activity of afGF,and has a potential to become a therapeutic agent as an aFGF antagonist.